Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
用户k7g3AjDeE8DM
2个月前
114
10
已完结
1. 系统已在2025-03-17 11:31:52对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S2213-8587(23)00388-1
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213858723003881
其他信息:
出版社: Elsevier BV
作者: Yiming Mu; Xiaolei Bao; Freddy G Eliaschewitz; Morten Rix Hansen; Bom Taeck Kim; Anna Koroleva; Ronald C W Ma; Tao Yang; Ning Zu; Ming Liu
